115 results on '"Ma, Kaifang"'
Search Results
2. VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
3. Association between vasectomy and risk of prostate cancer: a meta-analysis
4. Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
5. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
6. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features
7. Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway
8. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
9. Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
10. Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions
11. PD18-04 HAZARD OF DEATH IN VON HIPPEL-LINDAU DISEASE PATIENTS DEPENDS ON GENOTYPE AND ONSET AGE AS WELL AS FIRST AFFECTED LESION
12. Additional file 1 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
13. Additional file 5 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
14. Additional file 6 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
15. Additional file 2 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
16. Additional file 4 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
17. Additional file 3 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
18. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability
19. Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients
20. MP39-07 OVEREXPRESSION OF LNCRNA SUCLG2-AS1 INHIBITS CELL PROLIFERATION AND MIGRATION IN RENAL CELL CARCINOMA THROUGH MAPK SIGNALING PATHWAY
21. MP42-05 THE EXPRESSION LEVEL OF PD-L1 IS CORRELATED WITH CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH VHL-RELATED RENAL CELL CARCINOMA
22. PD52-08 ANALYSIS OF RISK FACTORS FOR SURVIVAL AND PROGNOSIS OF PATIENTS WITH VON HIPPEL-LINDAU SYNDROME: A LARGE RETROSPECTIVE STUDY
23. Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions
24. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma
25. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19
26. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
27. The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population
28. Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study
29. Cell cycle arrest and senescence in P53-wild type renal carcinoma by enhancer RNA - P53-bound enhancer regions 2(p53BER2) through p53-dependent pathway
30. MP14-19 A NOVEL ANTI-EPOR CAR-T CELL FOR THE TREATMENT OF CLEAR CELL RENAL CELL CARCINOMA
31. MP80-14 SURVIVAL DIFFERENCES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE BASED ON POSITIVE AND NEGATIVE FAMILY HISTORY
32. MP50-17 NOVEL GENETIC CHARACTERIZATION AND PHENOTYPE CORRELATION IN VON HIPPEL-LINDAU (VHL) DISEASE BASED ON ELONGIN C BINDING SITE: A LARGE RETROSPECTIVE STUDY
33. MP80-13 RISK FACTORS FOR SURVIVAL IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE: A LARGE SINGLE-CENTER RETROSPECTIVE STUDY OF 734 VHL PATIENTS
34. PD45-07 PD-L1 EXPRESSION WAS ASSOCIATED WITH AGGRESSIVE CLINICOPATHOLOGICAL FEATURES IN PATIENTS WITH VHL-RELATED RENAL CELL CARCINOMA
35. Discovery and validation of the prognostic value of the lncRNAs encoding snoRNAs in patients with clear cell renal cell carcinoma
36. MP66-08 THE EFFECT OF ONSET AGE AND INVOLVED ORGANS ON OVERALL SURVIVAL IN VON HIPPEL-LINDAU DISEASE
37. The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients
38. Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients
39. Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel–Lindau Disease
40. Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors
41. MP25-08 THE EFFICACY AND SAFETY OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE
42. MP14-19 SURVIVAL DIFFERENCES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE BASED ON POSITIVE AND NEGATIVE FAMILY HISTORY
43. MP16-08 TRIB3 PROMOTES THE PROLIFERATION AND INVASION OF RENAL CELL CARCINOMA CELLS VIA ACTIVATING MAPK SIGNALING PATHWAY
44. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma – a retrospective study using TCGA database
45. Distinctive clinicopathological features of Von�Hippel‑Lindau‑associated hereditary renal cell carcinoma: A single‑institution study
46. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients
47. Intra-familial phenotypic heterogeneity and telomere abnormality in von Hippel-Lindau disease
48. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway
49. Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients
50. Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.